Arcoma AB (OSTO:ARCOMA) Cyclically Adjusted FCF per Share: kr0.05 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:ARCOMA Arcoma AB OSTO:ARCOMA
75 GF Score
Price kr8.44
GF Value kr7.88
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Arcoma AB Cyclically Adjusted FCF per Share?

Arcoma AB OSTO:ARCOMA -1.40% 75 Cyclically Adjusted FCF per Share is kr0.05 as of Mar. 2026. GuruFocus rates OSTO:ARCOMA with a GF Score™ of 75/100 and a GF Value™ of kr7.88 (Fairly Valued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Arcoma AB's adjusted free cash flow per share for the three months ended in Mar. 2026 was kr-0.100. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is kr0.05 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-20), Arcoma AB's current stock price is kr8.44. Arcoma AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was kr0.05. Arcoma AB's Cyclically Adjusted Price-to-FCF of today is 168.80.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Arcoma AB was 187.60. The lowest was 148.80. And the median was 168.40.


Arcoma AB  (OSTO:ARCOMA) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Arcoma AB's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=8.44/0.05
=168.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Arcoma AB was 187.60. The lowest was 148.80. And the median was 168.40.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Arcoma AB Cyclically Adjusted FCF per Share Related Terms


Arcoma AB Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Arcoma AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arcoma AB Cyclically Adjusted FCF per Share Chart

Arcoma AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -3.68 -0.21 -0.05

Arcoma AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.30 -0.09 -0.17 -0.05 0.05

OSTO:ARCOMA vs ABT, SYK, MDT: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Arcoma AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arcoma AB Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Arcoma AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Arcoma AB's Cyclically Adjusted Price-to-FCF falls into.


OSTO:ARCOMA
75GF Score
Arcoma AB OSTO:ARCOMA
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arcoma AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Arcoma AB's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.1/133.5600*133.5600
=-0.100

Current CPI (Mar. 2026) = 133.5600.

Arcoma AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.047 101.019 -0.062
201609 0.012 101.138 0.016
201612 0.437 102.022 0.572
201703 -0.456 102.022 -0.597
201706 0.035 102.752 0.045
201709 -0.230 103.279 -0.297
201712 -0.471 103.793 -0.606
201803 -0.288 103.962 -0.370
201806 -0.056 104.875 -0.071
201809 0.570 105.679 0.720
201812 -0.298 105.912 -0.376
201903 -0.102 105.886 -0.129
201906 -0.376 106.742 -0.470
201909 1.143 107.214 1.424
201912 -0.670 107.766 -0.830
202003 0.031 106.563 0.039
202006 -0.288 107.498 -0.358
202009 -0.202 107.635 -0.251
202012 0.078 108.296 0.096
202103 -0.063 108.360 -0.078
202106 -0.330 108.928 -0.405
202109 -0.488 110.338 -0.591
202112 0.410 112.486 0.487
202203 -0.438 114.825 -0.509
202206 0.610 118.384 0.688
202209 -0.225 122.296 -0.246
202212 -0.271 126.365 -0.286
202303 0.074 127.042 0.078
202306 0.146 129.407 0.151
202309 -0.036 130.224 -0.037
202312 1.088 131.912 1.102
202403 0.243 132.205 0.245
202406 0.127 132.716 0.128
202409 0.353 132.304 0.356
202412 0.191 132.987 0.192
202503 -0.363 132.825 -0.365
202506 0.513 133.699 0.512
202509 -0.092 133.480 -0.092
202512 0.812 133.390 0.813
202603 -0.100 133.560 -0.100

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of kr0.05 mean?
Arcoma AB (OSTO:ARCOMA) has a Cyclically Adjusted FCF per Share of kr0.05 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Arcoma AB and its competitors.
Is Arcoma AB's Cyclically Adjusted FCF per Share too high?
Arcoma AB's current Cyclically Adjusted FCF per Share is kr0.05. Overall, Arcoma AB has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Arcoma AB's Cyclically Adjusted FCF per Share compare to ABT and SYK?
Arcoma AB's Cyclically Adjusted FCF per Share of kr0.05 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Arcoma AB and its competitors. Arcoma AB's current Cyclically Adjusted FCF per Share is kr0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arcoma AB stock overvalued right now?
Based on GuruFocus' analysis, Arcoma AB (OSTO:ARCOMA) is currently considered Fairly Valued. The stock's GF Value™ is kr7.88, compared to a current price of kr8.44 — trading 7.1% above its estimated fair value. The current Cyclically Adjusted FCF per Share is kr0.05. Arcoma AB's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Arcoma AB (OSTO:ARCOMA), the current Cyclically Adjusted FCF per Share is kr0.05 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arcoma AB (OSTO:ARCOMA) Overvalued in 2026?

Based on GuruFocus' analysis, Arcoma AB stock appears to be overvalued. The current stock price of kr8.44 is trading 7.1% above its estimated GF Value™ of kr7.88. GuruFocus considers Arcoma AB to be Fairly Valued.

Key valuation signals for OSTO:ARCOMA:

  • Cyclically Adjusted FCF per Share: kr0.05
  • GF Value™: kr7.88 vs. price of kr8.44 (7.1% above fair value)
  • GF Score™: 75/100 with 2 warning signs

No single metric tells the full story. See the OSTO:ARCOMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Arcoma AB Business Description

Address Annavagen 1, Vaxjo, SWE, SE-352 46
Arcoma AB provides digital radiography systems in Sweden. It offers products including wireless flat panel detectors, positioning devices, and precision dr systems.
75GF Score

Get the complete analysis for OSTO:ARCOMA

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr8.44
Price
kr7.88
GF Value